Doxycycline Dosing for Infected Dermal Cyst
For an adult with an infected dermal cyst, the recommended doxycycline dose is 100 mg twice daily by mouth.
Dosing Rationale
The 2014 IDSA guidelines for skin and soft tissue infections clearly specify doxycycline dosing at 100 mg bid (twice daily) orally for adults with skin and soft tissue infections 1. This dosing applies whether treating methicillin-susceptible Staphylococcus aureus (MSSA) or methicillin-resistant Staphylococcus aureus (MRSA) infections.
The FDA-approved dosing confirms this regimen, specifying:
- Initial dose: 200 mg on day 1 (administered as 100 mg every 12 hours)
- Maintenance dose: 100 mg daily for routine infections
- For more severe infections: 100 mg every 12 hours (which is appropriate for an infected cyst) 2
Clinical Context for Infected Dermal Cysts
An infected dermal cyst (epidermoid or pilar cyst) typically represents a skin and soft tissue infection that may involve:
- Staphylococcus aureus (both MSSA and MRSA)
- Streptococcus species
- Mixed skin flora
The 100 mg twice daily dosing is appropriate because:
- Infected cysts represent more than simple superficial infections
- The cyst cavity requires adequate antibiotic penetration
- This dosing maintains therapeutic serum levels for 24 hours 2
Treatment Duration
Based on IDSA guidelines, treatment duration should be 7 days depending on clinical response 1. Continue therapy until signs of infection (erythema, warmth, tenderness, purulent drainage) have resolved.
Important Caveats
- Incision and drainage is primary treatment: Antibiotics alone are insufficient for infected cysts with purulent collections. The cyst should be drained first, with antibiotics as adjunctive therapy 1
- Administration considerations: Give with food or milk if gastric irritation occurs, though absorption is not significantly affected 2
- Adequate hydration: Administer with plenty of fluids to reduce risk of esophageal irritation 2
- Bacteriostatic agent: Doxycycline is bacteriostatic with limited recent clinical experience in SSTI compared to beta-lactams 1
When Doxycycline May Not Be First-Line
While doxycycline is listed in IDSA guidelines, it's noted as having "limited recent clinical experience" for SSTI 1. Consider alternative agents like:
- Cephalexin 500 mg four times daily (preferred for MSSA)
- Trimethoprim-sulfamethoxazole (for MRSA coverage)
- Clindamycin 300-450 mg four times daily (for MRSA)
These alternatives may be preferred unless there are specific contraindications or resistance patterns favoring doxycycline.